N Verses Capital, LLC Nkarta, Inc. Transaction History
N Verses Capital, LLC
- $41.7 Billion
- Q1 2024
A detailed history of N Verses Capital, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 600 shares of NKTX stock, worth $4,104. This represents 0.02% of its overall portfolio holdings.
Number of Shares
600Holding current value
$4,104% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding NKTX
# of Institutions
119Shares Held
52.9MCall Options Held
145KPut Options Held
114K-
Boxer Capital, LLC San Diego, CA5.61MShares$38.4 Million3.15% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.19MShares$35.5 Million1.16% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.8MShares$26 Million0.08% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$25.8 Million12.85% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$24.4 Million2.71% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $333M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...